We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
4.1m buy followed by another 500k. Given some of the recent trades I’m expecting a holdings RNS.
large buy 20,000 shares
Hi no. gradual and pleasing rise but this company seems to be very conservative in providing news on anything. Re the court case they would legally not be able to say anything. In my view thought the US company pull stank given its timing and virus. Hope they can take them to the cleaners.
Doe anyone know what is happening here
Volume looks to be building as well. If it can break above 32p may add more.
Looks resistance around now then next stop 50p.
Rns first thing this morning. Only about ceo options. Gives him an incentive to get sp well above 60
What's going on?? 12% rise with no RNS Is there some news out there?
I think you may be right.
Hi, the thing you may be missing is that NIOX allows the docs to see airway inflammation. I dont know if this can also be applied to covid instead of a ct scan? Can it?
a good guess
I wouldn’t mind betting North Atlantic Smaller Companies has picked em up!!
Will be interesting to see who picked up the LO stake - should trigger an RNS
Lovely buy 2.9 million
Looks like my prediction is coming good. Strong price performance on Friday has been followed through today - this one is going to move quite a lot higher.
Better than too late
Too early?
I may be jumping the gun, but the price consolidation over the last few months looks to be drawing to a conclusion. A clear break above 28p or thereabouts would signal a clear path towards 60p.
I am getting in early.
Given broker research values CIR between 25p to 60p in time feels like shares are underpinned here. Yes, Covid19 has impacted Niox sales but they will recover and it is now a much cleaner and debt free business. Combine that with a very tight register and it wont take much to see these shares march higher. Don't forget the attractive management option scheme that kicks in at 62.5p....quite the incentive. The CFO did a great job for shareholders at Bioquell...expect the same result here. Topping up
yep, 2020 looks like it might well be pretty ugly, but otherwise Basic taking your example, if you assume another yr of revenue growth like 2019 and half the s&m and g&a do disappear, then you're getting pretty close to a positive result.
with focus being targeted almost entirely on an established product, NIOX, no product launches etc then achieving massive reductions to those costs isn't entirely unachievable.
i'm still wanting to believe that the grownups are managing this well, even with all the obstacles that covid and beyond air have thrown in.
LungFit™ PH (previously AirNOvent)
In January 2019, Circassia acquired the US and Chinese commercial rights to AirNOvent (now LungFit™ PH) from AIT Therapeutics Inc. (now BeyondAir Inc.). LungFit™ PH is a late-stage ventilator-compatible system that uses an electric voltage to produce nitric oxide from the nitrogen and oxygen in air. Inhaled nitric oxide is approved in the United States for use in the treatment of hypoxic respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN). PPHN is potentially fatal and its management can be complex, involving a number of treatments including the use of oxygen and inhaled nitric oxide.
Agreement status
Under the terms of the companies' agreement, Circassia issued BeyondAir $10.5 million in new ordinary shares as consideration for upfront and milestone payments. Additional milestones, which are payable in cash or shares, include a payment of $12.6 million on FDA approval in the treatment of hypoxic respiratory failure associated with PPHN, and a further $1.05 million on the product's launch in China. Royalties will also be payable on gross profits from product sales.
Under the terms of the agreement, BeyondAir is responsible for the product's development, manufacture and US regulatory filing, and it currently anticipates submitting an application for Premarket Approval (PMA) in Q2 2020 for use in the treatment of PPHN. Circassia is responsible for the product's commercialisation following approval.
At the end of 2019, BeyondAir issued a notice stating that it had terminated the companies' agreement for material breach. Circassia strongly disputes and intends to challenge BeyondAir's allegations and its purported termination. The Company has retained counsel and intends to take steps to enforce its rights under the agreement.
Your assessment makes a lot of sense if you’re taking a snapshot of the business in its current state - it’s difficult to really see what’s coming if you’re a retail investor.
My opinion is still mixed, but edging closer to optimism. Several funds have now invested, despite knowing (or at least they should have been able to predict) about the poor H1 2020 performance. We still have the support of RG, and the directors have stakes at around this price level. At this point in time, I’d say it’s a case of follow the money.
Going into H2 2020 and beyond, this really isn’t the same company anymore, but on that token, visibility into what’s next is somewhat unclear.
Not a word has been said about the dispute with BeyondAir, and the timing of that contract termination could well be suspect, so I only hope that the legal team are enthusiastically pursuing justice, if they truly believe there was no cause for termination.
My approach with CIR now is to think of the company of a somewhat clean slate, unburdened by debt and being influenced by some enthusiastic, tried and tested board members and professional investors.
Know what you’re buying - this is a turnaround story stock and we’re not really buying based on past performance.
I have seen various posts saying that everything is going to be all right here in 18 months time with the business being sold at 62.5p because Griffiths, Johnson, Roller have done this before, but I must be missing something. This is now a NIOX only business. Their 2019 NIOX sales were £34.6 million at 74% gross margin = £25.6M gross profit. Sales and marketing costs were £55M and G&A costs £11M. Let's assume that half of this cost goes now that they have given up Tudorza and Duaklir and they spend nothing on R&D. They are still loss-making on NIOX to the tune of £7M or £8M. To get to a share price of 62.5p needs a market cap of close to £250M. Who is going to pay £250M for a loss making business? What am I missing?
and very disappointing tbh
As is stands there’s not really a load to love in the results. Key will be what they look like in 6-12 months to demonstrate this transformational situation.....
The new holding is North Atlantic Smaller Companies investment trust top up nothing to be nervous about au contraire